Viewing Study NCT00159432


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-06 @ 2:40 AM
Study NCT ID: NCT00159432
Status: COMPLETED
Last Update Posted: 2014-07-29
First Post: 2005-09-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None colorectal View
None cancer View